Navigation Links
Delcath To Present At JMP Securities Healthcare Conference On July 12
Date:7/9/2012

NEW YORK, July 9, 2012 /PRNewswire/ -- Delcath Systems, Inc. (NASDAQ: DCTH) announced today that executive management will present an overview of the Company's business strategy and recent corporate developments at the JMP Securities Healthcare Conference in New York on Thursday, July 12, 2012 at 1:30 P.M. ET.

A live webcast and subsequent archived replay of the presentation will be available at http://www.delcath.com/investors/events/.  The presentation archived replay will be available approximately one hour after conclusion of the live event for a period of 90 days.

About Delcath Systems

Delcath Systems, Inc. is a specialty pharmaceutical and medical device company focused on oncology. Delcath's proprietary system for chemosaturation is designed to administer high dose chemotherapy and other therapeutic agents to diseased organs or regions of the body, while controlling the systemic exposure of those agents. The Company's initial focus is on the treatment of primary and metastatic liver cancers. In 2010, Delcath announced that its randomized Phase III clinical trial for patients with metastatic melanoma in the liver had successfully achieved the study's primary endpoint of extended hepatic progression-free survival. The Company also completed a multi-arm Phase II trial to treat other liver cancers. The Company obtained authorization to affix a CE Mark for the Delcath Hepatic CHEMOSAT® delivery system in April 2011 and for the second generation hemofiltration cartridge for CHEMOSAT in April 2012. The right to affix the CE mark allows the Company to market and sell the CHEMOSAT system in Europe. The Company has not yet received FDA approval for commercial sale of its system in the United States. The Company continues with the preparation of its NDA submission and intends to seek FDA
'/>"/>

SOURCE Delcath Systems, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Delcath Systems, Inc. Secures $20 Million Credit Facility
2. Delcath Highlights First Quarter 2012 And Recent Accomplishments
3. Delcath to Webcast Managements Presentation at Annual Meeting of Stockholders
4. Delcath Prices $20 Million Public Offering of Common Stock and Warrants
5. Delcath To Offer Second Generation Hemofiltration Cartridge In U.S. Expanded Access Program
6. Delcath Announced Changes To Board Of Directors
7. Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector
8. Latest Findings in Breastfeeding Science Presented at Medelas 7th International Breastfeeding and Lactation Symposium
9. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
10. Enox Biopharma, Inc. To Present Today At IN3 Medical Device 360 Conference In London
11. Foundation for Managed Care Pharmacy (FMCP) Presents Awards for 2012 National P&T Competition and Best Posters
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... FRANKLIN, Ohio , Jan. 15, 2014  A novel wearable ... it easy and painless for patients to self-inject prescription drugs ... of disorders, including cancer, blood diseases, autoimmune deficiencies, and genetic ... expected to grow to $220B by 2018, according to analysts.   ...
(Date:1/14/2014)... 2014  Luminex Corporation (Nasdaq: LMNX ) today announced ... of 2013 on Monday, February 3, 2014. A press release ... of trading. (Logo: http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO ) ... operating highlights and financial results for the fourth quarter and ...
(Date:1/14/2014)... , Jan. 14, 2014 The Brandeis Medical Center, led ... a premier and affordable laser tattoo removal experience with ... Brandeis, focus is in providing high quality cosmetic services with cutting ... " Southern California has seen a ...
Breaking Medicine Technology:Enable Injections Presents A New Class of Injectors for Drug Delivery at PEPTalk, Drug Delivery Partnership Meetings 2Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 2Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 3Beverly Hills Physician Features Tattoo Removal with the Astanza Duality Laser, Offers $99 Special 2
... 29, 2011 ViewRay™, Inc., a privately held ... MRI-guided radiotherapy at the annual meeting of the ... – 4 in Miami Beach, Florida, with software ... radiation therapy system is being developed to feature ...
... 29, 2011 Medical Alarm Concepts Holding, Inc. (OTCQB: ... for capital that will be used to accelerate corporate ... first fully-monitored medical alarm system that allows users to ... third of this private investment group funding has already ...
Cached Medicine Technology:ViewRay Demonstrates Potential Therapy Applications for MRI-Guided Radiation at ASTRO 2011 2Medical Alarm Concepts Receives Growth Capital Injection and Commitment for Future Funding 2Medical Alarm Concepts Receives Growth Capital Injection and Commitment for Future Funding 3
(Date:4/23/2014)... Physical Activity on Mobility Limitation in Old Age , ... of mobility limitation in old age, whereas leisure-time physical ... study which followed up 5,200 public sector employees for ... Research Center in Finland and the Finnish Institute of ... wears the body and lasts for several hours a ...
(Date:4/23/2014)... Previous studies have shown that proliferation of endogenous ... damage to neurons and axons. From the perspective ... from Sun Yat-sen University in China observed the ... neural precursor cell proliferation and expression of basic ... the rat brain on the infarct side. The ...
(Date:4/22/2014)... industry leaders visited the New Jersey Institute of ... S. Bloom for the launch of the New ... provides a new model for business innovation through ... assets and investment. U.S. Senator Cory Booker, Panasonic ... Taylor, New Jersey Lieutenant Governor Kim Guadagno, New ...
(Date:4/22/2014)... that can provide primary care for low-income patients ... and insurance companies while improving patient health, researchers ... suggests that health clinics that avoid costs associated ... by lowering hospital admission rates and emergency room ... Penn State Altoona. , The researchers estimated ...
(Date:4/22/2014)... risk of pregnancy among women using a newer method ... 10 times greater over a 10-year period than using ... researchers at Yale University and UC Davis has found. ... Contraception , the study found the higher risk ... the brand name Essure. , "This study provides ...
Breaking Medicine News(10 mins):Health News:Midlife occupational and leisure-time physical activity limits mobility in old age 2Health News:Government and industry leaders herald launch of NJIT's New Jersey Innovation Institute 2Health News:Clinics not bogged down by red tape can ease health cost burdens 2Health News:Risk of pregnancy greater with newer method of female sterilization 2Health News:Risk of pregnancy greater with newer method of female sterilization 3
... Laparoscopic cholecystectomy (LC) has rapidly substituted traditional cholecystectomy, ... of cholelithiasis. ,Bile duct injury (BDI) remains the ... recent survey, published in the October issue of ... BDI has become more frequent with LC. ...
... one of the most neurotoxic plants in western Mediterranean ... are known to be neurotoxic.// This shrub produces a ... the berries. ,Ingestion of few fruits similar ... seizures, coma and apnea. ,A recent paper ...
... issue of the Academy of General Dentistry's monthly newsmagazine, ... and is the most important factor in the prevention ... of the population. ,"Flossing every 24 hours to ... said Gordon Isbell, DMD, MAGD, spokesperson for the Academy ...
... colleagues from Toyama University, Japan have found that supplementation ... children’s behavior. //Researchers have found that Docosahexaenoic acid (DHA), ... an important component of cell membranes of the retina ... boys who have lower concentrations of DHA in blood. ...
... beer and alcohol increases the risk of colorectal tumours, ... to a study. // ,The study, conducted by ... University, Stony Brook, New York, was meant to examine ... of significant colorectal neoplasia in a screening population., ...
... products that would help women protect themselves from sexually ... any form that is convenient to use such as ... microbicides will enable women to negotiate condom use or ... would also help avoid unwanted pregnancies, according to experts.,With ...
Cached Medicine News:Health News:Higher incidence of bile duct injury during laparoscopic cholecystectomy 2Health News:Poisoning by fruits similar to blackberries 2Health News:Alcohol Drinking Affects Risk Of Colorectal Tumours 2
A software program for simple, efficient pulse oximetry analysis, which enables easy viewing, analysis and report generation for pulse rate and SpO 2 ....
... ,MARS Technology is the next generation in ... addition to our current family of "digital ... of new technological breakthroughs in signal processing. ... signal resulting in superior performance during challenging ...
The NPB-40 Handheld Pulse Oximeter is both compact and affordable. It is simple to operate, provides spot-check monitoring of SpO 2 and pulse rate, and is compact enough to fit in your pocket....
... The Nellcor N-20PA Handheld Pulse Oximeter is ... The durable construction of the N-20PA has ... temperatures and conditions it has even ... is conveniently portable for spot check measurements ...
Medicine Products: